Beauty Launches

Lancome Announces Absolue Longevity MD Line

This triple-targeted system launches May 1 and is designed to address biological aging across three key life stages.

Author Image

By: Rachel Klemovitch

Assistant Editor

Lancôme announced its new Absolue Longevity MD collection. 

This skincare line is backed by 5 patents, over 20 years of L’Oreal Longevity research, 59 scientific studies, 26 scientific publications, and the first-of-its-kind technology that converts ingestible science to topical results.

The Absolue Longevity MD collection is built around three targeted treatments – Anticipate, Intercept, and Reset – designed to address biological aging across three key life stages.

Lancôme shifts the conversation from correcting wrinkles to supporting how skin functions over time, aligning with growing consumer interest in preventative health, longevity, and personalized skincare.

The Three-Pillar Longevity Product System 

  • Anticipate (35 and under) – A preventative cream designed to address visible biological aging signs before they appear. 
  • Intercept (35–55) – Available as a cream and lightweight silk serum, Intercept targets visible biological aging as it begins. 
  • Reset (55+) – A rich cream and high-performance serum designed to restore resilience once signs of aging are visible, aimed at accelerating faster cell turnover and improving skin bounce. 

The Longevity Era: Where Beauty Builds for the Future

JiYu Skin Expands into Longevity Skincare

Keep Up With Our Content. Subscribe To Beauty Packaging Newsletters